Published in Br J Clin Pharmacol on May 02, 2016
How to Screen for Non-Adherence to Antihypertensive Therapy. Curr Hypertens Rep (2016) 0.77
Relationship Between Adherence Rate Threshold and Drug 'Forgiveness'. Clin Pharmacokinet (2017) 0.77
Adherence to antipsychotic medication among homeless adults in Vancouver, Canada: a 15-year retrospective cohort study. Soc Psychiatry Psychiatr Epidemiol (2016) 0.75
Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study. Int Clin Psychopharmacol (2017) 0.75
Improving Medication Adherence: Keep Your Eyes on the Prize. J Gen Intern Med (2016) 0.75
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Measuring agreement in method comparison studies. Stat Methods Med Res (1999) 31.11
A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med (2001) 9.98
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS (2000) 8.86
How often is medication taken as prescribed? A novel assessment technique. JAMA (1989) 5.98
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis (2001) 5.43
Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS (2002) 4.42
Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care (1999) 4.35
Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav (2007) 4.07
A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol (2012) 3.72
The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns (1999) 3.45
Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav (2010) 3.08
Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence. Europace (2015) 2.96
Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol (1993) 2.43
Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother (2009) 2.34
Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behav (2007) 2.20
Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr (2003) 2.15
Results of a randomized controlled trial to assess the effects of a mobile SMS-based intervention on treatment adherence in HIV/AIDS-infected Brazilian women and impressions and satisfaction with respect to incoming messages. Int J Med Inform (2012) 2.14
A multi-method assessment of treatment adherence for children with cystic fibrosis. J Cyst Fibros (2006) 2.11
Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol (2011) 2.09
Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol (2000) 2.05
Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv (2007) 1.99
Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance. Sex Transm Dis (1999) 1.99
Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin (2009) 1.97
Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS (2002) 1.82
Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care STDS (2004) 1.75
Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs (2003) 1.75
Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. J Acquir Immune Defic Syndr (2002) 1.70
Testing a nurse-tailored HIV medication adherence intervention. Nurs Res (2006) 1.60
Drug adherence in Parkinson's disease. Mov Disord (2004) 1.59
The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. J Rheumatol (2003) 1.58
Measuring medication adherence: are missed doses reported more accurately then perfect adherence? AIDS Care (2000) 1.56
Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension. Am J Hypertens (2009) 1.55
A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res (2005) 1.55
Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care STDS (2008) 1.54
Medication adherence in patients with HIV infection: a comparison of two measurement methods. AIDS Read (1999) 1.53
Measuring compliance among oral contraceptive users. Fam Plann Perspect (1996) 1.50
Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Eur J Clin Pharmacol (2007) 1.46
Adherence to single daily dose of aspirin in a chemoprevention trial. An evaluation of self-report and microelectronic monitoring. Arch Fam Med (1996) 1.43
Adherence to antiretroviral medications in HIV: differences in data collected via self-report and electronic monitoring. Health Psychol (2006) 1.41
Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens (1996) 1.41
A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults. AIDS Patient Care STDS (2006) 1.38
Hemodialysis patients' noncompliance with oral medications. ANNA J (1999) 1.37
Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study. J Gen Intern Med (2007) 1.35
Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation (2004) 1.33
Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clin Infect Dis (2003) 1.33
Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359. J Acquir Immune Defic Syndr (2005) 1.33
Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients. BMC Med Res Methodol (2008) 1.32
Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy (1997) 1.30
Improved compliance measures: applications in an ambulatory hypertensive drug trial. Clin Pharmacol Ther (1990) 1.29
What role does measuring medication compliance play in evaluating the efficacy of naltrexone? Alcohol Clin Exp Res (2007) 1.26
The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophr Res (2008) 1.26
Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr Serv (2007) 1.23
An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol (2007) 1.23
Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant (2008) 1.22
The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophr Res (2007) 1.22
Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparators. Hypertens Res (2008) 1.21
Development and reliability of a correction factor for parent-reported adherence to pediatric antiepileptic drug therapy. Epilepsia (2010) 1.19
A comparison of adherence assessment methods utilized in the United States: perspectives of researchers, HIV-infected children, and their caregivers. AIDS Patient Care STDS (2009) 1.18
Patient adherence to prescribed antimicrobial drug dosing regimens. J Antimicrob Chemother (2005) 1.17
Validity of medication adherence self-reports in adults with type 2 diabetes. Diabetes Care (2012) 1.16
Compliance assessed by the Medication Event Monitoring System. Arch Dis Child (1991) 1.15
Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. J Clin Pharmacol (1994) 1.15
Factors associated with accurate self-reported adherence to HIV antiretrovirals. Int J STD AIDS (2003) 1.14
Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance. J Clin Epidemiol (2006) 1.14
Differences between self-reported and electronically monitored adherence among patients receiving antiretroviral therapy in a resource-limited setting. AIDS (2012) 1.13
Monotoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas. Swiss Med Wkly (2002) 1.10
Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve, HIV patients. HIV Clin Trials (2011) 1.10
Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis. Int J Tuberc Lung Dis (1998) 1.07
Physicians' ability to predict patients' adherence to antihypertensive medication in primary care. Hypertens Res (2008) 1.06
Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy. AIDS Patient Care STDS (2002) 1.06
Assessing the validity of self-reported medication adherence in hepatitis C treatment. Ann Pharmacother (2007) 1.04
Electronic measurement of adherence to pediatric antiretroviral therapy in South Africa. Pediatr Infect Dis J (2008) 1.04
Measurement and prediction of medication compliance in problem drinkers. Alcohol Clin Exp Res (2003) 1.02
Electronic monitoring of compliance to lipid-lowering therapy in clinical practice. J Clin Pharmacol (1999) 1.01
All that glisters is not gold: a comparison of electronic monitoring versus filled prescriptions--an observational study. BMC Health Serv Res (2006) 1.00
Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders. J Affect Disord (2009) 1.00
Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study. Bull World Health Organ (2011) 1.00
Measuring therapy adherence in Parkinson's disease: a comparison of methods. J Neurol Neurosurg Psychiatry (2006) 1.00
Assessment of sulfonylurea adherence and metabolic control. Diabetes Educ (1995) 0.99
Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. AIDS Care (2001) 0.98
A novel approach to monitoring adherence to preventive therapy for tuberculosis in adolescence. J Paediatr Child Health (1999) 0.97
Pharmacists' interventions using an electronic medication-event monitoring device's adherence data versus pill counts. Ann Pharmacother (1993) 0.97
Use of electronic monitoring in clinical nursing research. Clin Nurs Res (2008) 0.97
Methods for measuring, enhancing, and accounting for medication adherence in clinical trials. Clin Pharmacol Ther (2014) 0.96
Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures. J Acquir Immune Defic Syndr (2015) 0.96
Self-reported versus 'true' adherence in heart failure patients: a study using the Medication Event Monitoring System. Neth Heart J (2012) 0.96
The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients. AIDS Patient Care STDS (2009) 0.94
Measurement of patient compliance. Pharm World Sci (1998) 0.93
Identifying youth nonadherence in clinical settings: data-based recommendations for children and adolescents with inflammatory bowel disease. Inflamm Bowel Dis (2011) 0.93
Antihypertensive medication-taking. Investigation of a simple regimen. Am J Hypertens (1993) 0.93
The effect of reporting methods for dosing times on the estimation of pharmacokinetic parameters of escitalopram. J Clin Pharmacol (2009) 0.93
Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial. Antimicrob Agents Chemother (2013) 0.92
Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications. J Clin Psychiatry (1999) 0.92
Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia. Schizophr Res (2011) 0.91
Antiretroviral medication compliance in patients with AIDS. AIDS Patient Care STDS (1998) 0.90
A simple, novel method for assessing medication adherence: capsule photographs taken with cellular telephones. J Addict Med (2011) 0.90
Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder. AIDS Patient Care STDS (2012) 0.89